New glutamatergic target for alcohol and substance use disorder medications

Psychopharmacology (Berl). 2014 Apr;231(7):1429-31. doi: 10.1007/s00213-014-3496-3. Epub 2014 Feb 28.

Authors

Csaba Vadasz¹, Mariko Saito

Affiliation

¹ Nathan Kline Institute, Neurobehavioral Genetics, New York University School of Medicine, Psychiatry, New York, USA, VADASZ@NKI.RFMH.ORG.

PMID: 24619644
DOI: 10.1007/s00213-014-3496-3

No abstract available

MeSH terms

Alcohol-Related Disorders / drug therapy*
Excitatory Amino Acid Agonists / pharmacology
Excitatory Amino Acid Agonists / therapeutic use
Excitatory Amino Acid Antagonists / pharmacology
Excitatory Amino Acid Antagonists / therapeutic use
Glutamic Acid / metabolism*
Humans
Molecular Targeted Therapy*
Receptors, Glutamate / metabolism
Substance-Related Disorders / drug therapy*
Synaptic Transmission / drug effects*

Substances

Excitatory Amino Acid Agonists
Excitatory Amino Acid Antagonists
Receptors, Glutamate
Glutamic Acid